Encompass Health signals higher 2026 outlook with $6.41B-$6.49B revenue and $6.02-$6.25 adjusted EPS guidance

Amgen Q3 preview: What to expect

2026/11/02

iShares Treasury Floating Rate Bond ETF declares monthly distribution of $0.1716

2026/11/02

Roche gains FDA 510(k) clearance for cobas eplex respiratory panel

2026/11/02

Nuveen Churchill Direct Lending Corp. Q3 2026 Earnings Preview

2026/11/02